Dark Pigmentation on the Back: Evaluation and Management
For dark pigmentation on the back, first exclude melanoma using ABCDE criteria (asymmetry, irregular borders, heterogeneous color, large diameter >7mm, evolution/recent change), then evaluate for common benign causes including post-inflammatory hyperpigmentation, drug-induced pigmentation, or melasma-like patterns, with treatment focused on sun protection and topical depigmenting agents if cosmetically concerning.
Initial Evaluation: Rule Out Malignancy
The priority is excluding melanoma, which can occur on the back and carries significant mortality risk if missed 1. Examine any pigmented lesion for:
- Asymmetry in shape
- Borders that are irregular or poorly defined
- Color that is heterogeneous (multiple shades of brown, black, red, white, or blue)
- Diameter greater than 7mm
- Evolution - any recent change in size, color, or shape 1
Critical action point: Any lesion meeting these criteria requires complete excisional biopsy with 2mm margins under local anesthesia, sent for histopathologic examination 1. Never perform shave or punch biopsies of suspected melanoma as this prevents accurate staging. Refer urgently to dermatology or surgical specialist if melanoma is suspected - patients should be seen within 2 weeks 2.
Common Benign Causes of Back Hyperpigmentation
Once malignancy is excluded, consider:
Post-Inflammatory Hyperpigmentation
Most common in darker skin types (Fitzpatrick III-VI), occurring after any inflammatory process - acne, eczema, folliculitis, or trauma 3, 4, 5. This represents melanin accumulation in the epidermis or dermis following inflammation.
Drug-Induced Pigmentation
Accounts for 10-20% of acquired hyperpigmentation cases 6. Key culprits include:
- NSAIDs
- Antimalarials
- Amiodarone
- Tetracyclines (especially minocycline)
- Chemotherapy agents
Drug-induced pigmentation often worsens with sun exposure and may deposit in distinctive patterns 6.
Melasma-Pattern Hyperpigmentation
While classically facial, similar hormonal and UV-driven hyperpigmentation can occur on the back, particularly in women with darker skin types 7.
Diagnostic Approach
Wood's lamp examination helps differentiate epidermal (enhanced under Wood's light) from dermal (unchanged) pigmentation, which guides treatment selection 8. Epidermal pigmentation responds better to topical therapy.
Review medication history systematically, particularly the drugs listed above. Consider biopsy only if the clinical picture is atypical or diagnosis remains uncertain after initial evaluation.
Treatment Algorithm
First-Line: Universal Measures
- Strict sun protection is mandatory regardless of cause 7, 9. Use broad-spectrum sunscreen protecting against both UV and visible light, especially important in darker skin types 9.
- Discontinue offending medications if drug-induced pigmentation is suspected 6
Second-Line: Topical Therapy
Hydroquinone 4% remains the gold standard first-line topical treatment for hyperpigmentation 5, 9. Apply to affected areas once or twice daily.
Combination therapy enhances efficacy 7, 9:
- Hydroquinone + tretinoin + topical corticosteroid (triple combination)
- Hydroquinone + kojic acid
- Hydroquinone + glycolic acid
Alternative agents if hydroquinone is contraindicated or ineffective 3, 10:
- Tranexamic acid (topical or oral)
- Kojic acid
- Azelaic acid
- Vitamin C derivatives
Third-Line: Procedural Options
Consider for refractory cases 10, 9:
- Chemical peels (glycolic acid, salicylic acid) - use caution in darker skin types due to risk of paradoxical post-inflammatory hyperpigmentation
- Laser therapy - Q-switched lasers may be effective but carry higher risk in richly pigmented skin 9
Important caveat: Procedural treatments in darker skin (Fitzpatrick IV-VI) require experienced practitioners, as improper technique can worsen hyperpigmentation 5, 9.
Emerging Therapies
Autologous platelet concentrates (PRP/PRF) show promise for hyperpigmentation with good safety profiles, though protocols remain unstandardized 7. Consider as adjunctive therapy in combination with topical agents.
Management as Chronic Condition
Hyperpigmentation should be managed as a chronic condition requiring 7:
- Regular follow-up every 3-6 months
- Maintenance therapy even after improvement
- Ongoing sun protection counseling
- Realistic expectations - treatment often requires 3-6 months to show visible improvement 10
Key Pitfalls to Avoid
- Missing melanoma - Always examine the entire back systematically, not just the area of concern
- Aggressive treatment in dark skin - Chemical peels and lasers can cause worsening hyperpigmentation if not performed carefully 5, 9
- Inadequate sun protection - Treatment will fail without strict photoprotection 7, 9
- Premature discontinuation - Patients often stop treatment before adequate trial period (minimum 8-12 weeks)
- Ignoring medication history - Always review current and recent medications systematically 6